Evidence map›Paper›PMID 16047198›Full record

ArticlePlanta2005

Enhanced resistance to early blight in transgenic tomato lines expressing heterologous plant defense genes.

Scott C Schaefer, Ksenija Gasic, Bruno Cammue, Willem Broekaert, Els J M van Damme, Willy J Peumans, Schuyler S Korban

Abstract read
PubMed Publisher
In one paragraph

Article in Planta, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Plant antimicrobial peptides.Folia microbiologica · 2014
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Scott C SchaeferDepartment of Natural Resources and Environmental Sciences, 310 ERML, University of Illinois, 1201 W. Gregory, Urbana, IL 61801, USA.
Ksenija Gasic
Bruno Cammue
Willem Broekaert
Els J M van Damme
Willy J Peumans
Schuyler S Korban
Ghent University · BEIllinois Department of Natural Resources · USKU Leuven · BEUniversity of Illinois Urbana-Champaign · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genes coding for an iris ribosomal-inactivating protein (I-RIP), a maize beta-glucanase (M-GLU), and a Mirabilis jalapa antimicrobial peptide (Mj-AMP1) were separately introduced into tomato (Lycopersicon esculentum cv. Sweet Chelsea) cotyledons via Agrobacterium tumefaciens-mediated transformation. Transgenic lines carrying each of the transgenes were confirmed for integration into the tomato genome using Southern blot hybridization. Transcription of I-RIP, M-GLU, and Mj-AMP1 genes in various transgenic lines was determined using Northern blot analysis. Plants of selected transgenic lines were inoculated with a 2-3x10(4) conidial spores/ml suspension of the fungal pathogen Alternaria solani, the causal agent of tomato early blight. Compared to control (non-transformed) plants, two transgenic lines carrying either a M-GLU or Mj-AMP1 showed enhanced resistance to early blight disease. None of the four lines carrying the I-RIP transgene showed increased resistance to early blight.

Indexed as

Genes, PlantAgrobacterium tumefaciensAlternariaGene ExpressionGlycoside HydrolasesIris PlantMirabilisN-Glycosyl HydrolasesPlant DiseasesPlant ProteinsPlants, Genetically ModifiedRibosome Inactivating Proteins, Type 1Solanum lycopersicumTransformation, GeneticZea maysGlycoside HydrolasesMAP protein, Mirabilis jalapaN-Glycosyl HydrolasesPlant ProteinsRibosome Inactivating Proteins, Type 1

Identifiers

PMID16047198
OpenAlexW2026922572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.